RxDoctor Payments Data

Heather Wilson, MD

Obstetrics · Louisville, KYNPI 1013971431

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $850 of the $950 with a category attached, or 89.5%. 13 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 30.6% of the total. Reporting peaked in 2022 at $224 and has fallen 60.8% since, to $88 in 2025.

$950in general payments, 2019–2025

Across 24 payments — averaging $39.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$291
  • Hologic Sales And Service, LLC$167
  • Mayne Pharma Commercial LLC$124
  • Astellas Pharma US Inc$100
  • AbbVie$90
  • Coopersurgical, Inc.$42
  • plus $137 from 7 others

What the payments were for

  • Food & beverage$85089%
  • Education$10011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few obstetrics providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$8,946
Medicare patients
62
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol25$966
Estradiol (Once Weekly)Estradiol12$573
Ibandronate Sodium23$503
ProgesteroneProgesterone, Micronized14$349
Oxybutynin Chloride14$225
Levothyroxine Sodium11$67

Paid to pharmacies, not to this prescriber.

Other obstetrics in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →